Treatment of hyperkalemia in children with intravenous salbutamol.

Abstract	The aim of this study is to investigate the efficacy and safety of intravenous salbutamol in hyperkalemia. Fourteen children with chronic renal failure, three with acute renal failure and hyperkalemia were treated by intravenous infusions of 4 micrograms/kg salbutamol. Reductions in the mean plasma potassium (K+) concentrations obtained at 40 to 120 min after therapy were statistically significant when compared with the mean plasma K+ concentration at the beginning of therapy (P < 0.01).
Authors	A Noyan, A Anarat, M Pirti, Z Yurdakul
Journal	Acta paediatrica Japonica : Overseas edition (Acta Paediatr Jpn) Vol. 37 Issue 3 Pg. 355-7 (Jun 1995) ISSN: 0374-5600 [Print] Australia
PMID	7645387 (Publication Type: Journal Article)
Chemical References	Blood Glucose Albuterol Potassium
Topics	Albuterol (pharmacology, therapeutic use) Blood Glucose (metabolism) Child Female Humans Hyperkalemia (drug therapy, etiology) Infant Infusions, Intravenous Male Potassium (blood) Renal Insufficiency (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!